# Evaluation of an Orally Administered Medication When Taken in Conjunction With Pramlintide

> **NCT00044707** · PHASE2 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 24 (actual)

## Conditions studied

- Diabetes Mellitus, Non-Insulin-Dependent

## Interventions

- **DRUG:** Pramlintide acetate

## Key facts

- **NCT ID:** NCT00044707
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-08
- **Primary completion:** 2002-09
- **Final completion:** 2002-09
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2015-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00044707

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00044707, "Evaluation of an Orally Administered Medication When Taken in Conjunction With Pramlintide". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00044707. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*